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In the United States more than “a billion pounds of butter, 7 billion pounds of cheese, 1.5 
billion pounds of yogurt, and one billion gallons of ice cream” (USDA, 2005) are produced 
annually. According to the USDA Food Pyramid, it is recommended that every person consume 
between two and three cups of milk products every day (USDA, 2005). With these large 
numbers in mind, one can easily see why a question is raised when it comes to what exactly is in 
dairy products and are these components harmful to humans? The greater question is, “What are 
the policies surrounding these antibiotic residues and their testing methods?”   
 In a 1988 study 71% of test samples from farms and the retail market tested positive for 
antibiotic residues; 63% of which were tetracyclines and sulfonamides in the United States (Milk 
Safety Branch, 1992). With such high percentages it can be seen that not only do the effects of 
these antibiotic residues need to be tested, but actual safe-levels of antibiotic residues for human 
ingestion must also be determined. Once safe-levels are determined, test methods that can be 
completed on a large or a small scale must be created in order to test for those levels. An 
international standard must be created to ensure justice to people worldwide. There must also be 
an education of farmers, veterinarians, and those in and around the dairy industry worldwide. 
This education must focus on the importance and hazards of safe protocol when dealing with 
milk and antibiotic residues on a regional, national, and international level. 
 Dairy cows commonly get pathogenic infections, which require antibiotic treatment. The 
most common and frequently occurring infection causes mastitis. Mastitis is an inflammation of 
the milk-producing glands causes great pain to the dairy cows. (Althaus, 2003) Some antibiotics 
are given to young calves to help them combat common bacterial diseases so they can grow to 
their full potential. These antibiotics include all of the antibiotics used in adult cows. (WHO, 
2001) Depending on the individual cow’s metabolism of the antibiotic as well as the dose of 
2antibiotic being administered, some antibiotics can be excreted out of the cow in its milk. The 
majority of antibiotics found in milk include beta-lactams, sulfonamides, and tetracyclines. 
Penicillin, a beta-lactam antibiotic, is the most widely used antibiotic in the dairy industry.  
The beta-lactam antibiotics include a series of drugs composed of one consistent structure, 
the beta-lactam ring (Fig. 1 in red) with side groups that can be modified to alter the 
biochemistry of the molecule.   
Figure 1: Beta-Lactam ring in Red 
Beta-lactam antibiotics act on the penicillin binding proteins. When bound, these antibiotics 
inactivate cell wall synthesis in a pathogen, thus killing the bacteria. (Jacoby, 2005) These are 
broad-spectrum drugs used to treat gram-positive and gram-negative bacterial infections. About 
10% of all people given beta-lactam antibiotics have allergic reactions to them (Rossi, 2004).  
The second group, the sulfonamides, is synthetic antibiotic that mainly targets 
streptococci. Many people have severe allergic reactions to sulfa drugs; medicines are clearly 
labeled if they contain a sulfa derivative. (Rossi, 2004) Sulfonamides are analogous to para-
aminobenzoic acid and, through competitive binding, inhibit the synthesis of dihydropteroic acid, 
a necessary step in the folic acid metabolism of pathogens (Fig. 2). (Gaskins, 2002)  
3Folic Acid      
Figure 2: Folic Acid Cycle in Pathogen 
If a pathogen is unable to produce necessary metabolites the pathogen will die.  
Tetracyclines are also synthetic antibiotics used to target the streptomyces bacteria. 
Tetracyclines also have a common ring structure (Fig. 3) and act by inhibiting protein synthesis 
in the pathogenic cell.  
4Figure 3: Tetracycline Structure 
Particularly, this drug inhibits the transfer riboneucleic acid from binding with the ribosome in 
the bacterial cell; therefore transcription cannot occur, inhibiting the protein synthesis required 
for bacterial survival. (Chopra, 2001)  Tetracyclines are very dangerous especially when taken 
by a pregnant mother, as they are teratogenic to the developing fetus. Also, tetracyclines are 
known to become more toxic after their expiration date. Thus, the use of “expired” tetracyclines 
as a common practice holds particular danger. When used improperly or over-used, all three of 
these above mentioned drug classes can be quite dangerous to the human population. Yet these 
are predominantly the drugs used most frequently in the treatment of dairy cow diseases.  
 Like in a human female, antibiotics can be excreted in breast milk. Thus, antibiotics and 
their metabolites get into the milk supply during milking. The antibiotics bind to proteins in 
blood serum and can be transferred from the blood into the milk. Of 37 common antibiotics Ziv 
and Sulman found that 75% of those antibiotics became bound in the serum at levels above 50% 
binding in the serum. (Ziv, 1972). When cows are on antibiotics their milk should not enter the 
milk supply. It is general practice to add milk from a cow that is receiving antibiotics only after 
5the recommended withholding time approved by the FDA. This duration would suggest that all 
antibiotic residue has left the body, however this is not always the case. Each cow is an 
individual and it can take longer, on a cow-to-cow basis, to leave the system. (Ziv, 1972).  When 
antibiotic-contaminated milk is put into the bulk tank it contaminates the entire tank of milk. 
These accidents can occur due to the cow’s individual metabolism to clear the drug, carelessness 
of a farmhand or greed to enter more milk into the bulk supply. Just looking at a vial of milk will 
give no information if it has been contaminated with antibiotics. Testing must be done to ensure 
no accidents have occurred. This is done at the dairy creamery. Milk from the bulk tank from the 
farm is transferred to the creamery where it is tested in a lab and then distributed to other 
factories to be bottled or made into other products. It is then shipped to retail stores where the 
consumer can purchase it for use. Different products made at the creameries include whole milk, 
skim milk, condensed skim milk, cream, and powdered milk. Milk containing antibiotic residues 
can get into any of these final products and be distributed for human consumption if not for 
rigorous safety standards and residue testing.  
The potential hazards of ingesting antibiotic residues in contaminated milk include 
“allergic reactions, interference in the intestinal flora, and resistant populations of bacteria in the 
general population” (Althaus, 2003). Perhaps the most dangerous of these hazards is the potential 
for creating resistant populations of bacteria. The few bacteria that survive antibiotic treatment 
have a resistance to the antibiotic. This “super-bug” can reproduce more clones of resistant 
bacteria. Repeated ingestion of certain antibiotic residues from infected cows to humans can 
increase the likelihood of creating resistant bacterial forms. Population resistance refers to the 
resistance and tolerance acquired by a bacterial population to a given antibiotic. (WHO, 2001) 
The transfer of resistance occurs through an R-plasmid transfer. An R-plasmid is a small amount 
6of bacterial genomic DNA that codes for added proteins not normally found in the bacterial 
genome. Not only can this R-plasmid be transferred within species of bacterial, but intraspecially 
as well-- this can include from a cow host to a human host. This transferable drug resistance 
causes great concern, especially because it can be transferred between species, because common 
bacterial infections that were once easily curable will soon become incurable and new drugs will 
have to be developed and tested. (Kruse, 1994) This will not only create a need for new drugs, 
but there will also be new bacterial species introduced into the population. Tolerance is gained 
through an excessive use of antibiotics as well as using too many broad-spectrum drugs to cure a 
bacterial or viral infection (Milk Safety Branch, 1992). Perhaps the biggest problem with 
resistance is that it is very hard to monitor. If a resistant pathogen is identified in a human host, it 
is not common to trace its origin to the milk supply. Many resistant pathogens could have arisen 
unwittingly from the milk supply. (WHO, 2001)  
 A second concern of antibiotic residues in milk is the chance of an allergic reaction. 
Allergies to antibiotics occur when the body’s immune system attacks the antibiotic, which is 
often a haptenic metabolite of the antibiotic and some carrier tissue. (DeSwarte, 1984). Small 
levels of antibiotics can be very hazardous to susceptible humans causing acute to severe 
reactions. For those people with very low tolerance for allergens a small amount of residue could 
induce a severe allergic reaction, sometimes leading to death. These reactions occur because 
immunoglobulin IgE antibodies activate primarily the mast cells and basophiles, which are the 
effector cells in the immune system. The effector cells then cause an inappropriate response on 
the cells they activate, which in turn causes increased inflammation within the body. This 
inflammation can in turn produce various side affects at different locations in the body. (Hsieh, 
2004) Although this may seem like a severe hazard, there are not many recorded allergic 
7reactions linked to antibiotic residues in milk. This is mainly because most physicians do not 
think to check all the way down to the antibiotic residue levels in milk when a person presents 
with an allergic reaction. Since these antibiotics are prominent in society and used to treat many 
common illnesses, the physicians generally find some other mode of reaction to blame. (Milk 
Safety Branch, 1992) 
In addition to allergic reaction there is some indication in the science literature to suggest 
that antibiotics can induce cancer and other non-cancerous hazardous effects on the body. Drugs 
that were previously used as antibiotics such as Sulfamethazine and Nitrofurazone have been 
proven to be carcinogenic. Chloroamphenical, found occasionally in milk, was shown to cause 
bone marrow disease. (Milk Safety Branch, 1992) However, if there is a prevalent link between 
severe health effects and antibiotic residues in milk, the FDA immediately recalls that antibiotic. 
As a result, antibiotics such as Sulfamethazine and Nitrofurazone are no longer used because of 
their carcinogenic characteristic. Hazardous effects occasionally cannot be determined during 
drug development because some of the side effects take many years to emerge.  Unfortunately a 
few must suffer for the protection and safety of many.  
 There is an obvious need to determine the safe-level of residues of different antibiotic 
groups that find their way into the milk supply. These include finding the levels that are safe for 
human ingestion as well as the development of more rigorous, timely, and efficient testing 
methods. In the U.S. safe-levels are identified through the government agency Hazard Analysis 
Critical Control Point (HCAPP). The HACCP is responsible for looking at different steps within 
general practice and making them safer. HACCP has a milk and dairy branch, working in 
conjunction with the FDA, to ensure proper steps will be taken. The FDA sets the safe-level by 
first identifying the lowest level of antibiotic that can be detected in a sample of milk. It then sets 
8this point as the most antibiotic allowed in the milk. (Sischo, 1996) The World Health 
Organization has left the determination of testing methods and safe-levels up to the responsibility 
of each individual country. However, the Codex Alimentarius was designed to set levels that are 
generally followed on an international scale. All countries do not currently adhere to these 
standards. (Hall, 2004) Here in the United States the FDA creates many national regulations, but 
leaves procedure up to the 55 milk-testing laboratories in the United States. Throughout Europe 
and ally European Nation, the European Union determines the safe-levels. (WHO, 2001) 
In order to test milk for safe-levels, different testing protocols and methods must be 
designed to produce accurate results at or near the safe-level standard. (Hall, 2003) There are 
tests that take a long time, such as the Bacillus stearothermophilus test and the use of high 
performance liquid chromatography (HPLC). The Bacillus stearothermophilus test uses this 
species of bacteria and a zone of inhibition to determine if antibiotics are present. The milk 
sample is placed on an agar plate inoculated with B. stearothermophilus. If a ring forms around 
the milk deposition bacterial growth has occurred, antibiotics present in the milk have created a 
zone of inhibition. Titration and standardizations using several control samples will allow one to 
estimate the amount of antibiotic residue in the sample. This time-consuming test is not designed 
for bulk testing nor does it allow for the quantification, in parts per billion, of antibiotic residues 
in the milk. It is not a good choice in an industry that needs to get accurate and precise results 
quickly. However, it is still used routinely in Canada, along with other testing methods. (Wehr, 
2004) HPLC employs a series of chemical reactions that separate components found within the 
milk. As each component is eluted by size one can then determine its exact type and quantity. 
(Wehr, 2004) These are expensive machines; not all lab-testing facilities can afford them, even in 
a first world country. (Althaus, 2003)  
9Quicker, less expensive, tests are needed in an industry that handles so many billions of 
gallons of milk a year. The two main tests that have been approved internationally are the 
DelvoTest and the Charm test. The DelvoTest takes approximately two and a half hours to 
complete, while the Charm test takes less than ten minutes to run. (Wehr, 2004) The Charm test 
has been designed to detect all three of the major groups of antibiotics at very low levels, which 
is very effective in detection. The Association of Official Analytical Chemists has approved both 
of these aforementioned tests. (Milk Safety Branch, 1992) 
 The DelvoTest comes in two main forms: a laboratory-administered version to be used by 
a technician and an on-farm test that a farmer can conduct. The Delvo Test detects limits that are 
equal to the maximum amounts of residue limits for beta-lactams and sulfonamides, however it 
needs to be enhanced in order to detect tetracyclines at safe-level amounts. Agar, mixed with a 
pH indicator, is inoculated with Bacillus sterothermophilus var. cardolactis. A pill containing 
freeze-dried bacterial colonies and the milk are added to the agar and placed in an incubator at 
46-48°C for two and a half hours. (Wehr, 2004) If the milk sample is negative for antibiotics, 
then the bacteria will grow and produce byproducts. The byproducts create an acidic pH causing 
the pH indicator to change from purple to yellow. This test result would be marked as “not 
found”, meaning it is negative for antibiotics or that the antibiotics are below the maximum safe-
level. If antibiotics are present in the milk sample they would kill the bacteria; no color change 
would occur. Purple agar indicates the milk sample is positive for antibiotics at or above the 
established safe-level. (Althaus, 2003) This testing method is used on a regular basis in milk 
testing facilities in the United States, Canada, United Kingdom (European Union), and China. 
(Wehr, 2004; Hillerton, 1999; Chen, 1994)  
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The “on-farm” DelvoTest allows for the farmer to test his/her own cows. It is 
advantageous for a farmer to know beforehand if the cows are antibiotic positive; introducing 
tainted milk into the creamery would incur large financial penalties. Hillerton, et. al conducted 
an experiment in the United Kingdom on the on-farm DelvoTest. This study was to confirm the 
effectiveness and cause of repeated false positives. The results of this blind study of large-scale 
farms, independent producers, and test herds concluded that the main cause for false positives 
were improper test protocol. (Hillerton, 1999) To avoid this problem in the United States, 
regional governments allows farmers to send individual and bulk tank samples to have their milk 
tested by trained laboratory technicians. Many milk producers take advantage of this opportunity, 
thus avoiding the fees and harm associated with antibiotic residues and false positive tests. 
(Hillerton, 1999)  
The DelvoTest is also useful in detecting antibiotic residues in goat ewes’ milk. (Wehr, 
2004; Althaus, 2003) The test works in the same method as stated above. This is very helpful to 
the goat producers who often see very high rates of pathogenic disease. Sometimes this milk is 
too thick to run via other testing methods due to different component levels as opposed to cows’ 
milk. A test that is as accurate as the DelvoTest advantageous in the goat milk industry. Althaus 
et al determined that DelvoTest was useful and accurate in detecting antibiotic residues in goats’ 
milk. (Althaus, 2003)     
 The CharmSL (Safe Level) is used to detect beta-lactams, sulfonamides, and tetracyclines. 
The FDA approves the CharmSL test because the assay detects levels closest to the pre-
determined safe-levels. In a 1992 Milk Safety Branch House committee hearing, the safe levels 
for the three groups of drugs were given as: “beta-lactams: 4.8ppb, tetracyclines: 200ppb, and 
sulfonamides: 10ppb” (in parts per billion). Salter, et al. completed the quantitative analysis and 
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the accuracy of the CharmSL test using beta-lactams, as well as non-beta-lactam drugs, in order 
to define the safe-levels. This study led to the federal certification of the CharmSL test. The 
countries mentioned previously that use the DelvoTest also employ the use of the CharmSL 
testing method. Many use the DelvoTest as a back up to the Charm test to ensure a check and 
balance system before the milk is sent out for further processing to avoid the report of a positive 
test to the government. (Salter , 2001)  
 Charm Sciences, Inc.®, maker of the Charm tests, provides testing material to the United 
States, Canada, and countries that follow the European Union and Codex Levels of testing. 
Charm Sciences® has also made different tests that account for the different safe-levels that each 
country has set. For the Charm Test there are individual assays for the three main antibiotic 
groups. (Charm Science® also produces a series of testing supplies for other antibiotic residues, 
not as prevalent and not required to be tested) Below are tables of the safe-levels for different 
antibiotics within the three groups as well as a comparison between the United States/Canada 
and EU/Codex standards. 
Table 1a: U.S. Beta-Lactam Standards 
Antibiotic Charm SL Detection Level 
(ppb) 
U.S. Regulation (ppb) 
Amoxicillin 5.6 10 
Ampicillin 8.5 10 
Cephaprin 13.7 20 
Ceftiofur 46 50 
Penicillin G 3.6 5 
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Table 1b: EU/Codex Beta-Lactam Standards 
Antibiotic Charm SL Detection Level 
(ppb) 
EU/Codex Regulation (ppb) 
Amoxicillin 3 4
Ampicillin 3 4
Cefalexin 30 100 
Cefazolin 12 50 
Cefaquinome 15 20 
Ceftiofur 30 100 
Cephapirin 6 60 
Cloxacillin 25 30 
Dicloxacillin 20 30 
Penicillin G 2.4 4 
Table 2: U.S. Sulfonamide Regulations 
Antibiotic Charm SL Detection Level 
(ppb) 
U.S. Regulation (ppb) 
Sulfadimethoxine 6.7 10 
Sulfamethazine 6.2 10 
Table 3a: U.S. Tetracycline Regulations 
Antibiotic ROSA Detection Level (ppb) US Safe Level (ppb) 
Chlortetracycline 150-300 300 
Oxytetracyline 150-300 300 
Tetracycline 30-90 400 
Table 3b: EU/Codex Tetracycline Regulations 
Antibiotic Detection Level (ppb) EU/Codex MRL (ppb) 
Chlortetracycline 70-100 100 
Oxytetracyline 70-100 100 
Tetracycline 15-30 100 
(Charm Sciences, Inc ®, 2007) 
 Although these tests are utilized in many countries, other countries do not test milk at all 
or their testing methods fall below the standards. Although the Codex Alimentarius is currently 
the accepted international standard, each country can decide for itself what levels and tests are 
acceptable. Since the World Health Organization has not developed a global policy surrounding 
the testing methods or actual safe-levels, there is an inequality in the world when it comes to the 
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quality of milk products. The FDA, as well as the European Union, approves the few tests 
mentioned above, yet there are still many countries that lack testing technology or requirements 
surrounding the testing of milk. Inadequate testing technology does not produce the same 
accurate results as the DelvoTest and Charm tests do. It is incumbent upon the global community 
to stress the importance of these tests, set a standard, and ensure that the best testing methods are 
made available for all nations. (WHO, 2001)  
 Global policy should also include education on many levels. Safe milk supply begins 
with the farmers and pass through the dairy and food industry. Veterinarians and government 
officials are the last safeguard. All these parties need a firm understanding of the health 
implications of tainted milk. Perhaps the best example of the lack of education among dairy 
farmers can be found in an experiment completed by Chitandi and Sternesjo in Njoro, Kenya. 
This study compared variation of the number of positive samples on small versus large-scale 
dairy farms. They found that both large and small farms tested positive for antibiotics in their 
milk. However, the researchers found that the small-scale farms, on the whole, produced worse 
results. To determine the reason for this high percentage of positive samples, a questionnaire was 
designed. Three main problems were identified: “(i) lack of understanding of risks related to 
antibiotic contamination in food, (ii) poor or no treatment records, and (iii) lack of a monitoring 
system as major risk contamination.” (Shitandi, 2004) Even though this experiment focused on 
farmers in Africa, there is reason to believe lack of education in many countries results in tainted 
milk. There are positive milk samples that occur in all countries. Educating farmers on the 
importance of accurate record keeping as well as adequate determination of the cows’ status, as 
well as alerting them to the hazards and risks associated with these residues would go a long way 
in counteracting the broad scope of safe milk production. Finally, the farmers must make sure 
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that their farmhands are getting appropriate training on how that particular farm operates. In the 
United States, many farmhands are immigrants and speak English as their second language. This 
language barrier could be creating problems in the system that can be relieved.  
An excellent example of what education can do for a country’s milk supply can be found 
in Barbados. Hall et al conducted surveillance on products coming from animal origin there from 
1996 until 2003. This study found that 6% of the milk producers tested positive in the year 1996, 
however a steady decrease over the seven years of the experiment occurred. In 2003 it was found 
that only 1% of the milk producers tested positive for antibiotics. This is a tremendous decrease 
over a short period of time that can be attributed to personal visits from the researchers to the 
farmers to explain to them positive tests and the hazards of antibiotic residues. If this is 
something that can happen in a relatively small area that is a bit more underdeveloped than the 
United States and other larger nations, it is something that can be translated to the large scale and 
eventually come to fruition for many other countries. (Hall, 2004)     
Thus this concurs with the study by Torrence that certain safeguards should be instated: a) 
balanced record keeping, b) monitoring of the farmers’ practice, c) re-education of veterinarians, 
and d) development of stricter government standards.  Record-keeping documents need to 
include which cows get treated, what type of medication, and what dosage they receive. 
(Torrence, 2003) A monitoring system would include random visits to different farms to assess 
the amount of hazard at that particular location. The visiting team would be comprised of 
independent evaluators avoiding conflict of interest inherent in all industries. (Torrence, 2003)  
Veterinarians, not by lack of education or willfulness, are often part of the problem. In an 
area with many farms record keeping by veterinarians should include epidemiological analysis of 
pathogenic outbreaks and the antibiotic treatment regimes use to combat the outbreaks. This 
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would help map out how resistance is emerging in different pathogens regionally, possibly 
leading to new drug development. If veterinarians carefully track what is prescribed as 
medication they can also work in conjunction with the milk testing laboratories. For example, if 
there is a farm that continually repeats positive test results in milk, then there is obviously a need 
for that farmer to get a better understanding of the antibiotics and how they must be used 
correctly in the dairy industry. If a veterinarian is alerted to this farmer’s problem, the 
veterinarian can educate the farmer and review the dosing instructions with the farmer to ensure 
there is an understanding of how to properly treat his herd of cows.  
Finally there is a need for governments to be proactive about protecting the populace 
from antibiotic residues in milk. The World Health Organization, respected internationally, could 
proscribe the Codex Alimentarius as the international norm for the dairy industry. All countries 
would have to follow these standards and testing methods thus ensuring healthful milk supply 
across the globe.  
 The dairy farm industry is diverse, ranging from mega-producers to small family farms. 
The industry is dependent on the health of its herds and antibiotics, by necessity, are required to 
keep the milking cows healthy. A natural consequence of this required treatment is the 
production of antibiotic metabolites, which in high enough concentration are harmful to humans. 
Careful monitoring of antibiotic residues can govern the unnecessary introduction of these 
moieties into the milk supply. This will require the education of many parts of the enterprise and 
the creation of safe-level tests appropriate to keeping on top of the ever-changing market of the 
dairy industry. Thus, a global policy that includes education, monitoring, accurate and reliable 
tests, and global regulations must be enacted in order to ensure the justice and safety of people 
worldwide.  
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